Life science enterprises, including CROs, pharmaceutical companies and large academic medical centers are implementing large-scale, advanced quantitative multispectral image analysis. These applications have opened new avenues for cutting-edge research and discovery. As this trend continues to grow in both its scope and impact, the demand on core software functionality to facilitate management, collaboration, and broader translation of multispectral analysis has become an increasingly significant hurdle.
Join Proscia and Akoya Biosciences, two industry-leading multispectral analysis companies, as they share the exciting new ways their platforms address these hurdles and how they impact your high-throughput analysis workflows.
You Will Learn
- How high-throughput tissue analysis workflows can drive your research
- How Proscia simplifies and speeds up your digital pathology workflow
- How Phenoptics enables better spatial biomarker discovery
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…